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Abstract
Objective To establish whether reinstitutionalisation
is occurring in mental health care and, if so, with what
variations between western European countries.
Design Comparison of data on changes in service
provision.
Setting Six European countries with different
traditions of mental health care that have all
experienced deinstitutionalisation since the
1970s—England, Germany, Italy, the Netherlands,
Spain, and Sweden.
Outcome measures Changes in the number of
forensic hospital beds, involuntary hospital
admissions, places in supported housing, general
psychiatric hospital beds, and general prison
population between 1990-1 and 2002-3.
Results Forensic beds and places in supported
housing have increased in all countries, whereas
changes in involuntary hospital admissions have been
inconsistent. The number of psychiatric hospital beds
has been reduced in five countries, but only in two
countries does this reduction outweigh the number of
additional places in forensic institutions and
supported housing. The general prison population
has substantially increased in all countries.
Conclusions Reinstitutionalisation is taking place in
European countries with different traditions of health
care, although with significant variation between the
six countries studied. The precise reasons for the
phenomenon remain unclear. General attitudes to
risk containment in a society, as indicated by the size
of the prison population, may be more important
than changing morbidity and new methods of mental
healthcare delivery.
Introduction
Since the 1950s, deinstitutionalisation has dominated
mental healthcare reforms throughout western
Europe. Large asylums have been closed or downsized,
and the total number of psychiatric hospital beds has
Data sources are listed on bmj.com
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fallen dramatically. Mental health services have been
established in the community, albeit with significant
variation between countries.1–4
Community mental health care is being further
developed in the United Kingdom through substantial
additional investment in specialised teams such as
assertive outreach and early intervention. It has been
argued, however, that the new era of reinstitutionalisa-
tion has already begun and has occurred largely unno-
ticed by the public and with little professional debate.5
Major characteristics of reinstitutionalisation are the
rising numbers of forensic beds, involuntary hospital
admissions, and places in supported housing.
However, the argument has as yet not been based on
systematic and precise figures.
This paper presents data from six European coun-
tries representing different traditions of health care.
We aimed to establish whether reinstitutionalisation is
taking place and, if so, to what extent and with what
variation between European countries. We also wished
to investigate whether reinstitutionalisation compen-
sates for the loss of conventional psychiatric hospital
beds and how it compares against changes in the
general prison population. This rate can be seen as a
non-healthcare indicator of societal tendencies to risk
containment, and data suggest that psychiatric
morbidity is high among prison inmates.6
Methods
The study included data from six European countries
that fulfilled the following criteria: experience of major
mental health reforms involving deinstitutionalisation
within the second half of the 20th century; availability
of reliable and reasonably complete data; and
representation of different traditions of mental health
care, including Scandinavian, central European, and
Mediterranean countries. We thus included England,
Germany, Italy, the Netherlands, Spain, and Sweden.
We collected data on forensic beds, involuntary
hospital admissions, places in residential care or
supported housing, conventional psychiatric hospital
beds, and the general prison population. For each of
these categories, we investigated how numbers have
changed since 1990. We chose this period of time
because 1990 has a historical significance as the end of
the post-war period in Europe and the beginning of a
new political era.7 If reliable data for the period since
1990 or for the whole country could not be
established, we used shorter periods and regional data.
As healthcare systems and legislation in the six
countries vary considerably, the precise definitions of
forensic beds, involuntary hospital admission, and sup-
ported housing also differ between some countries but
have been consistent over time within each country.
Although supported housing is often regarded as an
alternative to asylums and therefore a sign of deinstitu-
tionalisation, it still represents a form of institutional-
ised care and protection.8
Results
The number of forensic beds and places in supported
housing have increased in all countries (table).
Involuntary admissions have risen in England, the
Netherlands, and, especially, Germany, but have fallen
slightly in Italy, Spain, and Sweden. The number of
psychiatric beds has been reduced in all countries. In
England, Spain, and Sweden, the number of psychiatric
beds that have been closed is greater than the total
number of additional forensic beds and places in sup-
ported housing that have been established in the same
period of time. In Italy and the Netherlands, the
increase in forensic beds and supported housing has
Number of forensic beds, involuntary hospital admissions, places in residential care or supported housing, psychiatric hospital beds,
and prison population in six countries in 1990-1 and 2002-3. Values are numbers per 100 000 population unless stated otherwise
Service provision England Germany Italy Netherlands Spain Sweden
Forensic beds:
1990 1.3 (1991) 4.6 2.0 4.7 (1991) 1.2 (1992) 9.8 (1993)
2002 1.8* (2001) 7.8 2.2 (2001) 11.4 (2001) 1.5 14.3 (2001)
Change (%) +38 +70 +10 +143 +25 +46
Involuntary admissions:
1990 40.5 (1991) 114.4 (1992) 20.51 16.4 33.8 39.0 (1992)
2001 50.3 190.5 18.14† 19.1‡ (1999) 31.8§ (2000) 32.4¶
Change (%) +24 +67 −12 +16 −6 −17
Places in supported housing:
1990 15.9 (1997) 8.9 8.8 (1992) 24.8 (1992) 5.1 (1994) 76.0 (1997)
2002 22.3 17.9 (1996) 31.6† (2000) 43.8 (2001) 12.7§ 88.1
Change (%) +40 +101 +259 +77 +149 +15
Psychiatric hospital beds:
1990 131.8 141.7 4.5 (1992) 159.2 59.5 (1991) 168.6
2001 62.8 128.2 (2000) 5.3† (2000) 135.5 43.0 (1999) 58.3
Change (%) −52 −10 +18 −15 −28 −65
Prison population:
1992 90 71 81 49 90 63
2002 141 (2003) 98 (2003) 100 100 136 (2003) 73
Change (%) +57 +38 +23 +104 +51 +16
See bmj.com for data sources.
*Data refer to restricted patients admitted to all (high security and other) hospitals.
†Data for Emilia-Romagna, a region in northern Italy with a population of 4 million.
‡Data for Drenthe, a rural area with 450 000 inhabitants.
§Data for Andalucia, the second largest region in Spain, with a population of 7 million.
¶Discharges from treatment under the Compulsory Care Act during a six month period.
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been much greater than any decrease in conventional
psychiatric bed numbers, whereas in Germany the bal-
ance is approximately equal. The general prison popu-
lation has grown in all countries by between 16% and
104%, and the two countries with the highest
imprisonment rate (England and Spain) have the low-
est rate of forensic beds. We found no clear sign of a
harmonisation of provision between countries.
Discussion
Limitations of methods
Comparing the absolute numbers of institutionalised
patients between countries is difficult because of inter-
nationally varying definitions of the reported forms of
care. The differences in definitions, legislation, and
healthcare systems cannot be overcome by a
descriptive study. Consistent definitions were used
within each country, however, and no major changes in
mental health legislation have occurred that substan-
tially altered the threshold for involuntary care. This
paper thus focuses only on changes over time, and
these processes can be synoptically interpreted.
Changes over time
Involuntary hospital admissions have not increased in
all investigated countries, and no clear link exists
between changes in involuntary admission rates and
changes in numbers of hospital beds. Institutions as
defined by bricks and mortar—that is, forensic hospital
beds and places in supported housing—have shown
significant rises.
The extent of the new process varies, with no clear
pattern of differences between northern and southern
Europe. We could speculate as to whether the increase
in institutionalised care since 1990 has compensated
for the loss of psychiatric beds in the three decades of
deinstitutionalisation before that. However, within the
same period of time more or less comprehensive serv-
ices for community care have also been established to
treat in the community patients with severe mental ill-
ness who, without these services, may well have been
admitted to hospital.3 4 Research suggests that these
developments have indeed embraced care for a
number of patients with severe mental illness.9 Why
health commissioners in six different countries have
still decided to invest heavily in additional institutional-
ised care is therefore unclear. This is particularly strik-
ing with respect to expensive forensic beds, as no
evidence exists to show that the number of homicides
committed by mentally ill people in the community
has risen in the process of deinstitutionalisation.10–13
Reinstitutionalisation or trans-institutionalisation?
Most of the data are consistent with the assumption that
deinstitutionalisation, the defining process of mental
healthcare reforms since the 1950s, has come to an end.
Although the number of psychiatric hospital beds has
further decreased in five of the six studied countries
since 1990, this was partly or more than compensated
for by additional places in other forms of institutional-
ised care. This evidence indicates, therefore, that a
degree of new institutionalisation does exist as an inter-
national phenomenon, despite wide differences in
healthcare systems between the countries studied here.
Whether this process should be described as reinstitu-
tionalisation or only as trans-institutionalisation (that is,
a mere shifting of placements from one structure to
another) remains debatable. It might depend on the
national balance between further reduction of hospital
beds on the one hand, and newly established institution-
alised care on the other. To clarify this, research is
needed on the type of patients using each of the current
designations (forensic, supported housing, psychiatric
hospital, prison) and how many patients with severe
mental illness are cared for outside of these defined
institutions.
Potential explanations
Several potentially testable hypotheses exist as to why
former deinstitutionalisation now tends to be compen-
sated, or even over-compensated, for by reinstitution-
alisation. The need for institutionalised care may have
risen because of a greater frequency of illness, severity
of illness, or both, possibly influenced by increasing use
of illegal drugs. Another reason may be the loss of
social support for mentally ill people in traditional
families—for example, because of women taking
professional roles instead of being domestic carers.
Mental health care may have widened its remit and
taken patients that it would not have considered as its
clientele 20 years ago, such as patients with personality
disorders, but no evidence exists that substantial num-
bers of these new patients have ended in supported
housing and forensic beds. Furthermore, private
providers may have successfully widened their share of
the market and secured profitable funding for an
increased supply of institutionalised care.8
The substantial increase in the general prison popu-
lation, however, suggests that reinstitutionalisation in
mental health care might not be due to specific factors
of morbidity or healthcare delivery, but might rather be
driven by a “zeitgeist” towards risk containment in 21st
century European society. This pertains even though we
do not know how the proportion of mentally ill prison-
What is already known on this topic
The bases for institutionalisation and
deinstitutionalisation in mental health care remain
poorly researched and understood
Isolated aspects of reinstitutionalisation have been
reported, mainly for the United Kingdom
It has been argued that reinstitutionalisation
reflects a new international pattern, but this is not
based on systematic evidence
What this study adds
Reinstitutionalisation in the form of newly
established forms of institutionalised mental
health care has occurred in different European
countries since 1990
The balance between further reduction of
psychiatric hospital beds and new provision of
institutionalised care varies between countries
The general prison population has increased in all
the countries, and this may be linked to the
processes of deinstitutionalisation and
reinstitutionalisation
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ers among the prison population has changed over
time. Whatever the case, the data provided here
underline the need for more specific research into the
phenomenon and causation of reinstitutionalisation. In
addition, a professional and public debate is needed on
the ethical basis for detaining and “institutionalising”
patients with severe mental illness.
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Use of clomifene during early pregnancy and risk of
hypospadias: population based case-control study
Henrik Toft Sørensen, Lars Pedersen, Mette Vinther Skriver, Mette Nørgaard, Bente Nørgård,
Elizabeth E Hatch
Clomifene is widely used for inducing ovulation.1 It is
structurally related to diethylstilbestrol, which has been
linked to vaginal and cervical clear cell adenocarci-
noma in women exposed in utero. The adverse effect is
less severe in sons, although links to testicular cancer
and urogenital anomalies, such as epididymal cysts,
have been reported.2 3 A recent study also found an
increased risk of hypospadias in the sons of women
exposed to diethylstilbestrol in utero.4 Clomifene has a
half life of about five days, but its metabolites have been
found in blood samples on day 22 of the menstrual
cycle and in faeces up to six weeks after administra-
tion.5 The occurrence of hypospadias may be
increasing. Little is known about the risk of
hypospadias in boys born to women who have used
clomifene to induce ovulation.
Methods and results
Our case-control study was done in the Danish
counties of North Jutland, Aarhus, Viborg, and
Ringkjoebing (population 1.6 million, with 65 383
male births in the study period: 1989 to 2002, North
Jutland 34 859; 1996-2002, Aarhus 20 382; and 1998-
2002, Viborg 4148 and Ringkjoebing 5 994).
We identified all cases of hypospadias that had a
full prescription history in the period 1989-2003 from
the Danish hospital discharge registry, which contains
all discharges from hospitals in Denmark since 1977
and includes 10 digit personal identifiers, surgical pro-
cedures, and up to 20 discharge diagnoses classified
according to ICD-8 (international classification of
diseases, eighth revision) until the end of 1993 and
ICD-10 after 1993. The codes for hypospadias in
ICD-8 are 752.20, 752.21, 752.22, 752.28, and 752.29;
in ICD-10, the codes are Q54.0, Q54.1, Q54.2, Q54.3,
Q54.4, Q54.8, and Q54.9.
We found a total of 319 cases of hypospadias (any
time post partum) in the four counties. From the Dan-
ish birth registry, which contains information on all
births in Denmark since 1 January 1973, we selected a
control group of 10 records of male births without a
diagnosis of hypospadias and with a full prescription
history during the same period. We matched cases and
controls for birth month, birth year, and county of resi-
dence of the child.
The Danish national health service reimburses part
of patients’ expenditure on many prescribed drugs,
including clomifene. The four counties have pharma-
cies equipped with electronic systems that record
information on the drug, dose, personal identification
number, and date of dispensing of the drug. All data
are transferred to a research database at Aarhus
University Hospital. The data from the four counties
are electronically available from 1 January 1989 (North
Jutland), 1 January 1996 (Aarhus), and 1 January 1998
(Ringkjoebing and Viborg). We took data on all
prescriptions for clomifene during the first trimester
and 90 days before conception. To avoid confounding,
we also took data about prescriptions for antidiabetic
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